We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
148 hedge funds and large institutions have $1.38B invested in Rocket Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,600% more call options, than puts
Call options by funds: $74K | Put options by funds: $2K
32% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 44
19% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 21
1.92% more ownership
Funds ownership: 96.21% → 98.13% (+1.9%)
1% more funds holding
Funds holding: 146 → 148 (+2)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
25% less capital invested
Capital invested by funds: $1.85B → $1.38B (-$470M)
Holders
148
Holders Change
+2
Holders Change %
+1.37%
% of All Funds
2.28%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
25
Increased
58
Reduced
44
Closed
21
Calls
$74K
Puts
$2K
Net Calls
+$72K
Net Calls Change
-$3.6M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$28.3M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$13.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10.7M |
| 4 |
Barclays
London,
United Kingdom
|
+$6.51M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
+$6.41M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$33.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.9M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$12.1M |
| 4 |
PA
Perceptive Advisors
New York
|
-$9.58M |
| 5 |
Goldman Sachs
New York
|
-$8.26M |
